<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The use and benefits of normobaric oxygen (NBO) in patients suffering <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> is still controversial </plain></SENT>
<SENT sid="1" pm="."><plain>RESULTS: Here we show for the first time to the best of our knowledge that NBO reduces both <z:chebi fb="0" ids="31882">NMDA</z:chebi>-induced calcium influxes in vitro and <z:chebi fb="0" ids="31882">NMDA</z:chebi>-induced <z:mp ids='MP_0002229'>neuronal degeneration</z:mp> in vivo, but increases oxygen and <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation-induced cell injury in vitro and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced brain damage produced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>CONCLUSIONS: Taken together, these results indicate that NBO reduces excitotoxin-induced calcium influx and subsequent <z:mp ids='MP_0002229'>neuronal degeneration</z:mp> but favors <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced brain damage and neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>These findings highlight the complexity of the mechanisms involved by the use of NBO in patients suffering <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>